Becton, Dickinson and Co. (BD) is investing in its U.S. manufacturing network to add capacity for critical medical devices, ...

Becton Dickinson (NYSE:BDX) said it plans to make additional investments in its U.S. manufacturing network to add capacity ...

Becton, Dickinson and Co. is increasing its U.S. manufacturing capacity for essential medical devices, including syringes, needles and IV catheters.

Supply chain issues are top of mind at medtech companies since President-elect Donald Trump threatened tariffs on goods from ...

Avery Dennison, in partnership with Turck Vilant Systems & Becton, Dickinson and Company, introduces BD iDFill Individual ...

Becton Dickinson (BDX) announced additional investments in its U.S. manufacturing network to add capacity for medical devices, including ...

Invent.ai is working with Alo Yoga, a luxury activewear brand, to transform the retailers inventory planning and ...

Becton Dickinson responded to mounting pressure from healthcare agencies by producing 19 million smart syringes globally in the first half of 2023. The US Centers for Disease Control and ...

Becton, Dickinson, headquartered in Franklin Lakes, New Jersey, said it plans to invest more than $30 million in 2025 to increase manufacturing of IV lines and boost output of catheter solutions.

Overall, BD is expected to increase its production of domestically manufactured safety-engineered injection devices by more than 40% and conventional syringes by more than 50%. The manufacturer has ...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced additional ...